Get started
Author

Rohan P Master

Observed name: Rohan P. Master
ORCID: 0009-0005-7474-2941
Observed ORCID: 0009-0005-7474-2941
OpenAlex ID: A5120568028
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al. · Clinical Cancer Research · 3
PDF
Supplementary Data2 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data3 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Data from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data6 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data1 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data5 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data4 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Abstract A051: Recurrent RRAS and RRAS2 mutations in lung cancer define actionable oncogenic drivers with therapeutic susceptibility to pan-RAS inhibition
2026 · Alexander J. Pfeil, Tom Zhang, et al. · Cancer Research
Works count: 9
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type